Saad Mark E sold AXSM
September 5, 2025 · Form 4 insider transaction
Saad Mark E sold 9,127 shares of Axsome Therapeutics, Inc. at $125.07 per share, a transaction worth $1.14M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
9,127
Price
$125.07
Total value
$1.14M
InsiderSaad Mark E
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 5, 2025
Filing dateSeptember 5, 2025
Shares owned after10,002
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Such transaction was pursuant to a pre-approved 10b5-1 plan which has now been completed.; Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options.; Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $125.00 and $125.22.